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Background and Terms of Reference as provided by the requestor
The background and Terms of Reference (ToR) as provided by the European Commission for the present document are reported in Section 1.2 of the scientific opinion on the ad hoc methodology followed for the assessment of the disease to be listed and categorised according to the criteria of Article 5, Annex IV according to Article 9, and 8 within the Animal Health Law (AHL) framework (EFSA AHAW Panel, 2017).
1.2.
Interpretation of the Terms of Reference
The interpretation of the ToR is as in Section 1.2 of the scientific opinion on the ad hoc methodology followed for the assessment of the disease to be listed and categorised according to the criteria of Article 5, Annex IV according to Article 9, and 8 within the AHL framework (EFSA AHAW Panel, 2017) .
The present document reports the results of assessment on bovine viral diarrhoea (BVD) according to the criteria of the AHL articles as follows:
• Article 7: BVD profile and impacts • Article 5: eligibility of BVD to be listed • Article 9: categorisation of BVD according to disease prevention and control rules as in Annex IV • Article 8: list of animal species related to BVD.
Data and methodologies
The methodology applied in this opinion is described in detail in a dedicated document about the ad hoc method developed for assessing any animal disease for the listing and categorisation of diseases within the AHL framework (EFSA AHAW Panel, 2017).
Assessment

Assessment according to Article 7 criteria
This section presents the assessment of BVD according to the Article 7 criteria of the AHL and related parameters (see Table 2 of the opinion on methodology (EFSA AHAW Panel, 2017) ), based on the information contained in the fact-sheet as drafted by the selected disease scientist (see Section 2.1 of the scientific opinion on the ad hoc methodology) and amended by the AHAW Panel. Bovine viral diarrhoea virus (BVDV) is a member of the Pestivirus genus of the family Flaviviridae.
3.1.1. Article 7(a) Disease Profile 3.1.1.1. Article 7(a)(i) Animal species concerned by the disease
Susceptible animal species
Parameter 1 -Naturally susceptible wildlife species (or family/orders) Evidence for natural susceptibility of wildlife species Ridpath and Neill, 2016) comes mainly from serological surveys. While these have typically demonstrated the presence of antibodies capable of neutralising BVDV, the possibility that they may in some cases indicate exposure to a different, but related, Pestivirus cannot be excluded. Those species from which BVDV has been isolated (or viral antigen/RNA detected), confirming their susceptibility are underlined below; otherwise natural susceptibility is based on serological evidence. Where only serological evidence of infection exists, it is recognised that due to the cross-reactive nature of pestiviral antibodies it is possible that these are due to infection with other pestiviral species and do not provide definitive evidence of susceptibility to BVDV (Ridpath and Neill, 2016 (Ridpath and Neill, 2016) Family Giraffidae Giraffe (Giraffa camelopardalis) (Ridpath and Neill, 2016) Family Antilocapridae Pronghorn (Artilocapra americana) (Ridpath and Neill, 2016) Family Camelidae Alpaca (Vicugna pacos) Dromedary (Camelus dromedarius) Guanaco (Lama guanicoe) Llama (Lama glama) Vicuna (Vicugna vicugna)
Family Suidae
Wart Hog (Phacochoerus africanus) Wild Boar (Sus scrofa) (Ridpath and Neill, 2016) 
Family Traguilidae
Mousedeer (Tragulus javanicus) (Grondahl et al., 2003) Order Lagomorpha
Evidence of susceptibility of Leporidae (order Lagomorpha) has been published. A study in wild rabbits in Germany found low levels of neutralising antibodies in 40/100 sera (Fr € olich and Streich, 1998) , although attempts at virus isolation were unsuccessful. A survey in the UK reported a weak positive result by enzyme-linked immunosorbent assay (ELISA) (and with high levels of non-specific binding) in 3/260 wild rabbits (Grant et al., 2015) , with the authors concluding BVDV is not established as an endemic infection of rabbits in the regions of the UK where sampling was conducted (Bachofen et al., 2014; Grant et al., 2015) . More recently, 34/94 sera from European hares were found to contain virus neutralisation (VN) antibodies to a ruminant pestiviruses with none testing positive for viral RNA by real time RT-PCR.
Family Leporidae
Rabbit (Oryctolagus cuniculus) (Fr € olich and Streich, 1998; Grant et al., 2015) European hare (Lepus europaeus) Parameter 2 -Naturally susceptible domestic species (or family/orders) BVDV is predominantly a pathogen of cattle, but interspecies transmission can occur following contact with sheep, goats and pigs. In common with cattle, infection of sheep can result in the birth of viable persistently infected (PI) lambs. In contrast, the birth of PI offspring appears to be a rare result of in utero infection in goats and pigs .
Order Artiodactyla
Family Bovidae
Cattle Sheep Goats
Family Suidae (Pigs)
Pigs
Parameter 3 -Experimentally susceptible wildlife species (or family/orders)
Family Leporidae
Rabbit (Oryctolagus cuniculus)
Challenge of New Zealand White rabbits with BVDV by the intravenous (IV) and oronasal (ON) routes, and via contaminated hay resulted in seroconversion in some or all rabbits in each group in the absence of clinically apparent disease (Bachofen et al., 2014) . All whole blood samples collected from each group during serial bleeds were negative by real time RT-PCR, as were oral swabs (providing no evidence for shedding by this route). Tissue samples and buffy coat were collected from rabbits challenged by the IV and ON routes, with some positive results, particularly following IV challenge. Virus isolation was attempted on ileum collected following IV challenge, with positive results.
IV challenge of pregnant rabbits did not result in clinical signs or increased rates of abortion or stillbirth (Grant et al., 2015) . Relatively few offspring (21%) had evidence of infection by real time RT-PCR at the end of the experiment (maximum 10 days of age), with a proportion of these also seropositive by ELISA. Persistence of infection was therefore not demonstrated.
to be susceptible to infection with BVDV (Baker et al., 1954) , although recent work has suggested that mice can be infected when inoculated by oral and intra-nasal challenge (Seong et al., 2015 (Seong et al., , 2016 .
Reservoir animal species
Parameter 5 -Wild reservoir species (or family/orders) Lack of strict host species specificity raises the possibility of reservoir species, but it has been considered that natural infections in species other than cattle and sheep do not represent a disease problem for control programmes in domestic ruminants (Løken and Nyberg, 2013) . Passler et al. (2016) propose four criteria that a potential wildlife reservoir must satisfy: (1) be susceptible to BVDV, (2) shed BVD (particularly through persistently infected animals), (3) maintain BVDV in the population, (4) have sufficient contact with cattle to allow spillback infections to occur. Applying these criteria to white-tailed deer (Odocoileus virginiansis) in the US, where they have been intensively studied in relation to BVDV, they conclude that they represent a low risk as an important reservoir species in most environments. In general, seroprevalence levels are much lower in wildlife than in cattle in endemic situations, suggesting that the former are spillover hosts rather than true reservoir species. Evermann (2006) suggests three proposed population groups for pestiviral infections: cervid, camelid and domestic ruminants, with pestiviruses (which may be distinct from BVDV) circulating within and, under optimum conditions, between these clusters. While this may result in disease, the potential for limited intrahost spread in the new population is suggested to limit the possibility of this leading to an epidemic in the new population.
In Europe, a number of studies have also investigated the seroprevalence of BVDV in deer, typically to examine their epidemiological importance in the context of national eradication programmes. A serosurvey of free-living deer from regions of Denmark with a relatively high prevalence of cattle herds with a persistent BVD infection status prior to its eradication from cattle found a very low prevalence of cervid infection (Nielsen et al., 2000) . The authors concluded that the positive animals were likely to have resulted from transmission from cattle to deer and that transmission among deer or from deer to cattle was highly unlikely and therefore that the possibility of free-living deer being a source of infection for cattle was remote.
A serological survey in Norway between 1993 and 2000 found 12.3% roe deer to be seropositive to BVDV, with the authors concluding that pestivirus is endemic in this species (Lillehaug et al., 2003) . While they noted the possibility of deer to cattle transmission impacting on eradication and surveillance within the Norwegian eradication programme, this has proven unfounded as demonstrated by the successful completion of the eradication programme (Løken and Nyberg, 2013) .
The role of wild ruminants, including red and roe deer, in the epidemiology of BVDV infections in domestic livestock in Switzerland was investigated (Casaubon et al., 2012) . The authors found that despite regular interactions with farmed ruminants, infection in wild ruminants was sporadic with VN antibodies not found in any of 435 roe deer and detected in only 13/476 red deer (2.7%). They concluded that wildlife was an incidental spillover host rather than a reservoir host for BVDV and as such did not represent a threat to the Swiss national BVDV eradication programme in livestock (Presi and Heim, 2010) .
A recent study in Belgium (Tavernier et al., 2015) of wild roe deer found only 1.3% seropositive, despite an expanding population and regular contact with livestock, concluding that they do not play an important role in the epidemiology of infection in domestic animals.
A similar study was conducted in the south of Spain (Paniagua et al., 2016) where wild ruminant populations have also increased substantially, resulting in the frequent sharing of habitats with domestic livestock. It found only 1 of 892 red deer to be seropositive and concluded that the deer were spillover hosts only and did not represent a risk for domestic ruminants. Another study of sympatric alpine populations of livestock and wild ruminants, including deer in north-west Spain generated similar findings (Fern andez- . Grant and others (Grant et al., 2015) consider that a wildlife reservoir in the rabbit (Oryctolagus cuniculus) poses a small but non-zero risk of re-infection for BVDV-free cattle herds. While this is unlikely to be of epidemiological relevance for most control scenarios, it may theoretically play a role in the tail end of an eradication campaign.
Detection of VN antibodies to pestiviruses, including BVDV, in European hares (Lepus europaeus) has led to the suggestion that they may be a wildlife reservoir, particularly in relation to the Pyrenean chamois .
Parameter 6 -Domestic reservoir species (or family/orders) Sheep and goats are susceptible to infection with BVDV. While both sheep and goats PI with BVDV have been described, foetal death and non-viability of lambs are common sequelae of transplacental infection in sheep and viable PI kids are considered a rare result of in utero infection in goats, where reproductive failure or gross pathology of infected foetuses are the likely outcome (Løken, 1995; Bitsch et al., 2000; Krametter-Froetscher et al., 2010; Passler and Walz, 2010) .
3.1.1.2. Article 7(a)(ii) The morbidity and mortality rates of the disease in animal populations
Morbidity
Parameter 1 -Prevalence/Incidence A series of investigations aimed at assessing the prevalence of BVDV infection have been performed in Europe, from the late seventies and into the 21st century, and the results of these at both animal- (Table 1 ) and herd-levels (Table 2 ) have been reviewed within the position paper published by the EU Thematic network on control of bovine viral diarrhoea virus (BVDV) (2001) .
The general picture is that in many European countries without systematic control in place, or before such measures were implemented, the infection has been/is endemic at a high level with 60-80% of the animals being antibody positive and 1-2% being persistently infected. In many countries, surveys indicated that almost all herds had antibody carriers and approximately half of them had PI animals. However, a few countries had quite a different picture with much lower prevalences. This heterogeneity in the presence of BVDV infection in the absence of systematic control was considered likely to be a reflection of the distribution of risk factors for new BVDV infections and for persistence of the infection in the respective countries.
Where a systematic approach has been adopted in MS, significant progress has been made. The Scandinavian Member States (MS) Sweden, Finland, Denmark have completed eradication programmes (as has Norway) (Stahl and Alenius, 2012; Løken and Nyberg, 2013; Foddai et al., 2014; Norstr € om et al., 2014; Finnish Food Safety Authority Evira, 2016) , while national or regional programmes are under way and have reduced the prevalence of PI births in a number of other MS, including Austria, Germany, Ireland, Scotland and Belgium (Rossmanith et al., 2010; Schirrmeier et al., 2012; Clegg et al., 2016; Duncan et al., 2016; Ribbens et al., 2016) and in Switzerland (Presi et al., 2011) . Parameter 2 -Case-morbidity rate (% clinically diseased animals out of infected ones)
Acute (transient) infections:
The case-morbidity rate for acute (transient) infections varies with a range of factors, including the age of the animal, its immune status and its reproductive state . The majority of acute infections are considered subclinical. However, infection of a BVDV na € ıve animal results in a transient viraemia which can be associated with short-term leukopenia, lymphopenia and/or thrombocytopenia, apoptosis in the thymus, and pyrexia. The resultant immunosuppression, particularly in calves, can allow other infectious agents to become established, or allow the recrudescence of existing infections resulting in enteric or respiratory disease. Infection of na € ıve breeding animals may have a range of negative outcomes depending on the stage of reproduction, including fertilisation failure, early embryonic death, abortion, congenital defects and the birth of PI offspring which may be weak, undersized and ill-thrifty. Acute infection of sexually active bulls results in a reduction in sperm density and motility, plus an increase in sperm abnormalities .
Following the emergence of BVDV II in North America, much higher case morbidity rates (and mortality rates) were reported (Carman et al., 1998) . The within-herd abortion rate was 44% (3-83%). The mortality rate was 53% (3-83%) for animals under 2 years of age and 9% (2-26%) for older animals. A recent study of BVDV type 2c in Germany reported a case-fatality rate of up to 60% and mortality in outbreak farms varied between 2.3% and 29.5% (Gethmann et al., 2015) . 
*: Note that the antibody detection methods vary between countries as do the cut offs when a herd is considered to have antibody carriers or PI animals. Prevalences are therefore just indicative of the level and not directly comparable between countries.
Persistent infections: PI animals have been shown to be significantly smaller than non-PI animals ( Table 3 ). The annual incidence risk of dying or being slaughtered due to unthriftiness was calculated as 0.28 and 0.31 among 34 PI animals in 10 Danish dairy herds (Houe, 1993) . Observational studies on the impact of infection with BVDV on health and production parameters have been reviewed in the EU Thematic network on control of BVDV (2001) and the results are reproduced below (Table 3) . BVDV is not considered zoonotic, although the ability of BVDV to replicate in human cell lines has been reported in some studies and there are limited reports of detection of virus, viral RNA or antigen in human samples (Giangaspero et al., 1997; Walz et al., 2010; Bratcher et al., 2012) .
3.1.1.4. Article 7(a)(iv) The resistance to treatments, including antimicrobial resistance Parameter 1 -Resistant strain to any treatment even at laboratory level Not applicable to viruses.
3.1.1.5. Article 7(a)(v) The persistence of the disease in an animal population or the environment
Animal population
Parameter 1 -Duration of infectious period in animals
Transiently infected (TI) animals: 0-14 days (Niskanen et al., 2002; Lindberg and Houe, 2005; Nickell et al., 2011; Sarrazin et al., 2014) .
Persistently infected animals: lifelong (Lindberg and Houe, 2005) .
Parameter 2 -Presence and duration of latent infection period True latency is not described for BVDV.
Parameter 3 -Presence and duration of the pathogen in healthy carriers Persistent infected animals may be apparently normal and healthy or small, weak and ill-thrifty: they are lifelong carriers and shedders of BVDV (Lindberg and Houe, 2005; .
Environment
Parameter 4 -Length of survival (dpi) of the agent and/or detection of DNA in selected matrices (soil, water, air) from the environment (scenarios: high and low T)
In general, pestiviruses including BVDV have limited ability to maintain their infectivity outside the host; it rapidly loses infectivity after contact with organic solvents and pH outside the range of 6.7-9.3, with sensitivity to low pH increasing with environmental temperatures from 4 to 37°C (Stevens, 2009) . The same author also examined the ability of BVDV to survive over a 96-h period on/in a range of surfaces and liquids, with or without mucus, including paper, latex gloves, cotton T-shirt, denim jeans, untreated pine wood, rubber boot, galvanised and enamelled buckets, mineral and salt blocks, total mixed ration (TMR), pen floor soil/manure, water and phosphate buffered saline (PBS).
The probability of virus being present decreased with time, with survival enhanced by the presence of mucus. Modelling predicted no virus present at 96 h in all cases. Virus survival was most prolonged in water and PBS, followed by on latex and enamelled metal, paper, galvanised metal, soil and pine and TMR. No virus was recovered from the cotton T shirt, denim, mineral or salt licks (Stevens, 2009) . Slurry: 105.2 TCID 50 /50 lL of BVDV was fully inactivated after 3 weeks, 3 days, 3 h, 50 min, 20 min, 5 min and 5 mins at temperatures of 5, 20, 35, 40, 45, 50 and 55°C, respectively (Bøtner and Belsham, 2012) .
Whole milk: BVDV was inactivated when whole milk was heated at 85-92.2°C for 10 min (although viral RNA could still be detected in some samples) (Marley et al., 2009) .
Whole and ground meat: BVDV was consistently inactivated when cooked to ≥ 75°C (Bratcher et al., 2012) .
BVDV is resistant to dry heat, not being significantly inactivated by one hour's exposure to temperatures between 75 and 95°C (Sauerbrei and Wutzler, 2009 ).
3.1.1.6. Article 7(a)(vi) The routes and speed of transmission of the disease between animals, and, when relevant, between animals and humans
Routes of transmission
Parameter 1 -Types of routes of transmission from animal to animal (horizontal, vertical)
Horizontal: Direct (nose to nose) and airborne over short distances in buildings where persistently infected animals are present and indirect via contaminated equipment, facilities and personnel (Gunn, 1993) . Spread of BVDV by ambient air or other vehicles involving TI animals has never been demonstrated and is most to be of marginal significance (Lindberg and Houe, 2005) . Virus may be shed in the semen of bulls (Rikula et al., 2008) , but avoidance of transmission by this route during artificial insemination using semen collected in MSs can be achieved through compliance with the requirements for intracommunity trade laid down in Council Directive 2003/43/EC 1 or the OIE guidelines on collection and processing of bovine, small ruminant and porcine semen (OIE, 2016b) . BVDV can also be transmitted by embryo transfer, but preliminary evidence indicates that the risk is negligible if in vivo embryos are collected and processed according to OIE guidelines (OIE, 2016a). Adventitious transmission by contaminated live vaccines has also been described (Løken, 1995) . Virus has been recovered from biting and non-biting flies following exposure to PI animals in experimental studies, but with one exception onward transmission of the virus has not been demonstrated (Gunn, 1993; Rikula et al., 2008; OIE, 2016b) .
Vertical: Transient infection of a na € ıve dam during the first third of pregnancy (up to approximately 125 days of gestation) will result in the birth of a PI calf if the foetus is carried to term. All calves born to PI dams will also be PI.
Parameter 2 -Types of routes of transmission between animals and humans (direct, indirect, including food-borne) Not relevant.
Speed of transmission
Parameter 3 -Incidence between animals and, when relevant, between animals and humans See below.
Parameter 4 -Transmission rate (beta) (from R 0 and infectious period) between animals and, when relevant, between animals and humans A basic reproduction ratio (R 0 ) of 0.25 (95% CI 0.01; 1.95) and 0.24 (95% CI 0.01; 2.11) was estimated for TI animals infected with a virulent BVDV-1b and a virulent BVDV-2a field isolate from Belgium, respectively. After introduction of a PI animal, an R 0 of +∞ (95% CI 1.88; +∞) was calculated. These results support the suggestion that TI animals, compared to PI animals, contribute only a limited amount to BVDV spread (Sarrazin et al., 2014) .
3.1.1.7. Article 7(a)(vii) The absence or presence and distribution of the disease in the Union, and, where the disease is not present in the Union, the risk of its introduction into the Union
Presence and distribution
Parameter 1 -Map where the disease is present in EU ( Figure 1 The disease is considered endemic in all MS in the absence of systematic eradication programmes (Tables 1 and 2) .
Where a systematic approach has been adopted in MS, significant progress has been made. The Scandinavian countries Sweden, Finland and Denmark have completed eradication programmes (as has Norway) (Stahl and Alenius, 2012; Løken and Nyberg, 2013; Foddai et al., 2014; Norstr € om et al., 2014; Finnish Food Safety Authority Evira, 2016) , while national or regional programmes are under way and have reduced the prevalence of PI births in a number of other MSs, including Austria, Germany, Ireland, Austria, Scotland and Belgium (Rossmanith et al., 2010; Schirrmeier et al., 2012; Clegg et al., 2016; Duncan et al., 2016; Ribbens et al., 2016) and in Switzerland (Presi et al., 2011) .
Risk of introduction
Infection is already present in MS.
3.1.1.8. Article 7(a)(viii) The existence of diagnostic and disease control tools
Diagnostic tools
Parameter 1 -Existence of diagnostic tools A range of reliable diagnostic tools for detection of virus, viral antigens, RNA and antibodies are available (see Section 3.1.4.1. Parameter 1).
Control tools
Parameter 2 -Existence of control tools Three central elements of systematic approaches to control and eradication of BVDV have been identified (Lindberg et al., 2006) : a) biosecurity and possible use of vaccination (Lindberg et al., 2006) aimed at preventing re-introduction of the infection in free herds b) elimination of PI animals from infected herds c) surveillance to monitor the progress of interventions and to rapidly detect new infections.
These have been applied independently, in a number of European countries, with Scandinavia now considered free of infection. Compulsory independent national or regional programmes are currently underway in a number of other countries, including Austria, Belgium, Ireland, Northern Ireland, Germany, Scotland and Switzerland (Stahl and Alenius, 2012; Sarrazin et al., 2013) . These programmes are not compulsory on an EU level.
However, EU level measures are in place to prevent trading of bovine semen and embryos from BVDV-infected donor animals. Council Directive 2003/43/EC lays down the animal health requirements applicable to intra-Community trade and imports of semen of domestic animals of the bovine species. The loss of production due to the disease Parameter 2 -Proportion of production losses (%) by epidemic/endemic situation Health and production losses from observational studies are summarised in Table 3 . Losses attributable to BVD arise from three main sources-reproductive losses, immunosuppression in calves and persistently infected animals (Gunn et al., 2004) . Estimates of economic/financial losses due to BVDV associated with initial outbreaks, the average losses at herd level and at national livestock level have been reviewed in the Report on the EU Thematic Network on control of BVDV. Various studies were carried out on the average financial losses for cattle herds. The estimations range from €30 to €60 per average cow present. At the level of the national livestock sector, studies indicated a loss due to BVDV under endemic conditions of € 15-20 per cow present. Compared to other production diseases such as mastitis and lameness, the financial-economic importance of BVDV can be considered as 'moderate'.
Some results are summarised in Tables 5, 6 and 7 for some countries (EU Thematic network on control of bovine viral diarrhoea virus (BVDV), 2001). The variation in the economic impact of BVDV at dairy farm level in a number of MS arising from uncontrolled output following introduction to a BVDV-naıve herd within year 1 of a 10-year epidemic represented 22%, 7%, 8%, 5%, 8% and 20% of the BVDV-free annuity for the UK, Northern Portugal, Holland, Norway, Italy and Germany, respectively (Gunn et al., 2005) .
Total loss attributable to infection with BVDV in New Zealand dairy herds was estimated at NZ$87 per cow/year in affected herds, and NZ$44.5 million per year overall, based on an estimated 14.6% affected herds (Heuer et al., 2007) .
The maximum annual output losses per cow in 50-cow suckler (cow-calf) beef herds in Scotland where the herd was either initially BVDV-free or of unknown status were estimated at £38.71 and £28.22, respectively (Stott et al., 2012) .
The average annuity equivalent of unchecked losses due to BVDV infection and re-infection in typical British hill suckler (cow-calf) enterprises over a 10-year disease ranged from almost £0/cow to approximately £40/cow per year, depending on the initial disease status of the herd, the initial source of virus, the probability and source of further infection, the probability of virus transmission within the herd and herd size (Gunn et al., 2004) .
Based on data for 1993, the annual financial loss due to BVD in Norway in the absence of control was estimated at approximately NOK 32.5 million (Valle et al., 2005) .
The annual losses to the Irish cattle industry due to BVDV were estimated at €102 million (Stott et al., 2012 ) (cattle population estimate in 2016: 6,613,400; Central Statistic Office Ireland).
Using an economic welfare model, the net discounted economic gain for Scotland of eradicating BVD from the Scottish dairy herd was estimated at £47 million over a 10-year eradication period (Weldegebriel et al., 2009) .
The annual cost of BVDV in the Australian cattle population was estimated to be AUS $57.9 million . Clinical signs may vary from inapparent to death, depending on a variety of factors including whether the animal is acutely or persistently infected.
Acute (transient) infections: Transient infection of na € ıve female breeding animals may have a range of negative outcomes depending on the stage of reproduction, including fertilisation failure, early embryonic death, abortion, congenital defects and the birth of PI offspring which may be weak, undersized and ill-thrifty; infection of na € ıve bulls may result in decreased sperm motility and density and increase levels of sperm abnormalities . Other clinical signs associated with acute infection include pyrexia, diarrhoea, decreased milk yield, sudden death and haemorrhagic syndrome (Ridpath et al., 2013; Gethmann et al., 2015) .
However, the majority of acute infections are considered subclinical, with seroconversion and recovery occurring 2-3 weeks post-infection (Ridpath et al., 2013; . Even in the absence of clinical signs infection of a BVDV, na € ıve animal results in a transient viraemia which can be associated with short-term leukopenia, lymphopenia and/or thrombocytopenia, apoptosis in the thymus, and pyrexia. The resultant immunosuppression, particularly in calves, can allow other infectious agents to become established, or allow the recrudescence of existing infections resulting in enteric or respiratory disease which may be fatal. Recent work demonstrating a significant reduction in thymic size following challenge of calves with both low and high virulence BVDV strains, accompanied by a significant depletion of thymic cortex, suggests that transient infection of neonatal calves may have long-term immunosuppressive effects (Ridpath et al., 2013) . Following the emergence of BVDV II in North America, much higher case morbidity rates (and mortality rates) associated with primary infection were reported (Carman et al., 1998) . The within-herd abortion rate was 44% (3-83%). The mortality rate was 53% (3-83%) for animals under 2 years of age and 9% (2-26%) for older animals. A recent study of BVDV type 2c in Germany reported a case-fatality rate of up to 60% while mortality in outbreak farms varied between 2.3% and 29.5% (Gethmann et al., 2015) . Persistent infections: PI animals can be clinically healthy, but some may appear small, weak and ill-thrifty, showing decreased weight gain, stunted growth and chronic ill thrift. PI animals are considered more susceptible to secondary infections leading to poor survivability of most PI animals. The annual incidence risk of dying or being slaughtered due to unthriftiness was calculated as 0.28 and 0.31 among 34 PI animals in 10 Danish dairy herds (Houe, 1993) .
In addition, PI animals are uniquely to susceptible to developing mucosal disease, which is inevitably fatal , with death occurring a few days to a few weeks following its onset.
Article 7(b)(iv) The impact of the disease on biodiversity and the environment
Biodiversity
Parameter 1 -Endangered wild species affected: listed species as in CITES and/or IUCN list
The CITES list contains a number of species in the Families Antilocapridae, Bovidae, Cervidae, Camelidae and Suidae, within the Order Artiodactyla. However, there is no specific data confirming their susceptibility to infection with BVDV (although a related pestivirus has been isolated from pronghorn (Ridpath and Neill, 2016) .
Parameter 2 -Mortality in wild species
Despite abundant evidence that pestiviruses currently circulate in wildlife populations, the full impact of exposure and prevalence of these infections are largely unknown (Ridpath and Neill, 2016) .
Environment
Parameter 3 -Capacity of the pathogen to persist in the environment and cause mortality in wildlife BVDV does not survive for extended periods in the environment (see Section 3.1.1.5 Parameter 4). Despite abundant evidence that pestiviruses currently circulate in wildlife populations, the full impact of exposure and prevalence of these infections are largely unknown (Ridpath and Neill, 2016) .
Article 7(c) Its potential to generate a crisis situation and its potential use in bioterrorism
Parameter (2015), with these being further categorised according to the purpose of the test (Table 8 ). Within Europe, availability of laboratories offering tests for both agent identification and detection of the immune response is high, with these commonly accredited to ISO 17025. Kits are readily available commercially.
Effectiveness
Parameter 2 -Se and Sp of diagnostic test See Table 9 . It is important that all assays are appropriately validated before use, particularly in relation to their ability or otherwise to detect both BVDV 1 and 2 (and other related pestiviruses) (Bauermann et al., 2012) . • Considered the gold standard test, but time-consuming and expensive to perform BVD vaccines are widely available in Europe and worldwide, but specific data on production capacities are lacking.
Parameter 3 -Field protection as reduced morbidity (as reduced susceptibility to infection and/or to disease) All vaccines licensed in MSs with a claim relating to foetal protection must satisfy the requirements of the BVD Monograph of the European Pharmacopoeia.
The role of vaccines in systematic control is as an additional biosecurity measure. In areas where the risk of introducing BVDV infection is known or perceived to be high, one option is to implement systematic vaccination in the initial stages of control/eradication programmes, after removal of PI animals. The need for including a vaccination regime will differ between countries/regions and it will also change over time, as the prevalence of infected herds decreases (EU Thematic network on control of bovine viral diarrhoea virus (BVDV), 2001). Even in this context, there are a number of additional factors that require consideration before using vaccines, including antigenic variation between vaccine and field strains, incorrect use of vaccines, lack of common understanding of the purpose of vaccination, the desirability of 100% efficacy of foetal protection, importance of complying with wider programme elements (not just vaccination), diagnostic confounding and the potential for live BVDV vaccines to be contaminated with adventitious viruses (Lindberg et al., 2006) . There is little information available on the field efficacy of vaccines. A meta-analysis of the efficacy of BVDV vaccination to prevent reproductive disease measured by risk of foetal infection, abortion risk and pregnancy risk revealed significant decreases of nearly 45% in abortions and nearly 85% in foetal infection rate in vaccinated cattle compared with unvaccinated cohorts (Newcomer et al., 2015) . When data relating to field challenge only were included, abortion risk was significantly reduced by 33%, while insufficient data were available for analysis regarding the risk of foetal infection. Additionally, pregnancy risk was increased by approximately 5% in field trials of BVDV vaccinates. It should be noted although that many of the vaccines used in this study are not licensed for use in the EU.
Parameter 4 -Duration of protection See Table 10 .
Feasibility
Parameter 5 -Way of administration See Table 10 . • Prevent introduction of PI animals and carriers OR • Prevent dams in early pregnancy from having direct or indirect contact with sources of BVD virus to avoid creation of PI calves. Lindberg and Alenius (1999) have reviewed risk factors for the introduction of BVDV into non-infected herds, evaluated the perceived need for control for each of these and proposed relevant control measures (Table 11 ). At least one susceptible animal in early pregnancy becomes infected due to usage of live vaccine contaminated with noncytopathic BVDV strains in the production process, or disease emerge as a result of recombinations between vaccines and field strains Ridpath and Bolin (1995) and Desport et al. (1996) No evidence exists that wild ungulates, swine or goats have transmitted the infection to cattle, even though interspecies transmission is possible Nettleton (1990) . Strains proven to be involved in transmission from sheep to cattle have been of bovine origin Paton et al. (1995 (1991) . Vector-borne transmission has never been described under natural conditions Parameter 2 -Effectiveness of biosecurity measures in preventing the pathogen introduction
Overall, the effectiveness of available biosecurity measures in preventing the entry of BVDV by direct or indirect routes is considered high when applied appropriately. One exception relates to the introduction of pregnant non-PI females carrying PI calves (referred to as Trojan animals) .
Parameter 3 -Feasibility of biosecurity measure
The biosecurity measures described are considered feasible. This has been proven by the number of successfully applied eradication programmes.
Article 7(d)(v) Restrictions on the movement of animals and products
Availability
Parameter 1 -Available movement restriction measures
The key restriction measure relates to the movement of PI animals. This is readily available through prior testing. Identification of Trojan dams by diagnostic testing prior to movement is not available, but has been addressed in eradication programmes by applying restrictions at herd level for a period following removal of PI animals (EU Thematic network on control of bovine viral diarrhoea virus (BVDV), 2001). Movement of TI animals is considered a much lower risk but is more difficult to address. A range of reliable diagnostic tools for detection of virus, viral antigens, RNA and antibodies are available (see Section 3.1.4.1. Parameter 1).
Additionally, measures are in place to prevent trading of bovine semen and embryos from BVDV-infected donor animals. Council Directive 2003/43/EC lays down the animal health requirements applicable to intra-Community trade and imports of semen of domestic animals of the bovine species.
Effectiveness
Parameter 2 -Effectiveness of restriction of animal movement in preventing the between farm spread Prevention of movement of PI animals is considered key to control. The effectiveness of movement controls is clearly dependent on the level of uptake/industry engagement, being most effective in the context of systematic control and least effective when participation/involvement is voluntary (Lindberg et al., 2006) .
Feasibility
Parameter 3 -Feasibility of restriction of animal movement PI animals comprise a small percentage of the population (Houe, 1999) and therefore restricting their movement is feasible. Restricting movements of pregnant females from herds where BVDV has been identified until sufficient time has elapsed to minimise the possibility of the sale of pregnant animals carrying PI calves is also feasible, but is more disruptive to trade and will affect a larger proportion of animals. Measures to prevent movement of TI animals are likely to have a greater impact still, although the duration of the measure at herd level is likely to be much shorter.
Article 7(d)(vi) Killing of animals
Availability
Parameter 1 -Available methods for killing animals PI animals are not excluded from the food chain subject to passing appropriate ante-and post-mortem inspection. Therefore, slaughter is normally carried out in abattoirs. Where juvenile PI animals are being culled, there are typically one or a small number of animals per herd which can be slaughtered by veterinary practitioners or knackery operators.
Parameter 2 -Effectiveness of killing animals (at farm level or within the farm) for reducing/stopping spread of the disease Identification and removal of PI animals is recognised to be key to stopping the spread of infection, both within and between farms.
Feasibility
Parameter 3 -Feasibility of killing animals Disposal of small numbers of PI animals either through abattoirs or on farm is feasible (and already happening in eradication programmes).
Article 7(d)(vii) Disposal of carcasses and other relevant animal by-products
Availability Parameter 1 -Available disposal option Depending on the age and health of the animal, carcasses and by-products may be disposed of through the abattoir system or by rendering.
Effectiveness
Parameter 2 -Effectiveness of disposal option Currently available disposal options are considered effective. Epidemiological-economic models used to develop a number of decision support tools in several countries at both herd and sectoral/national levels have been reviewed previously (EU Thematic network on control of bovine viral diarrhoea virus (BVDV), 2001). Overall the results at both levels were contradictory, with all studies having in common an emphasis on reducing the risk of re-introduction of BVDV as this had negative consequences on the financial-economic feasibility of prevention and control.
A recent systematic review of economic evaluations of worldwide BVDV control activities found that most studies provided only qualitative values of control activities and did not include an economic methodology in their study design (Richter et al., 2016) .
A loss-expenditure frontier method was used to compare control strategies in Scottish suckler (cow-calf) beef herds to identify strategies with the maximum net benefit from combining output losses and control expenditure (Stott and Gunn, 2008) . Consistent with a previous report (Houe, 2003) , there was no single strategy that generated the best outcome; while the mean net benefit was consistently positive, it varied with herd size and initial herd status (na € ıve or unknown).
A study of producer and consumer benefits arising from eradication of BVDV from Scottish dairy herds estimated that while there was an overall discounted economic gain of £47 million over 10 years, this was unevenly distributed, with milk consumers gaining £11 million and producers with infected herds gaining £39 million, while those with uninfected herds lost £2 million (Stott et al., 2010) .
Parameter 2 -Cost of eradication (culling, compensation) In contrast to other diseases, eradication of BVDV, be it from individual farms or complete livestock sectors, is possible. In other words, the potential gross benefits of eradication of BVDV might be larger than those of other diseases. The costs of such programmes can apparently vary quite a lot, thereby affecting their benefit/cost ratio (BCR). The Norwegian study shows positive financial-economic effects (i.e. a BCR larger than 1) already over a 10-year period, when the annual BVD programme costs were subtracted from the benefits, a net positive value for the entire period of NOK 130 million (Valle et al., 2005) . In contrast, in a French study where it took approximately 15 years to reach breakeven. It should be noted that these two examples applies clearly different control schemes. However, no single advice applicable for all situations exist. Specific conditions could determine the profitability of nation-wide programs (EU Thematic network on control of bovine viral diarrhoea virus (BVDV), 2001).
Analyses of Scandinavian programmes have shown a positive cost benefit. For example Houe (Houe, 2003) reports costs associated with the first 3 years of the Danish eradication programme of approximately $9 million/year, with annual costs of approximately $3.5 million for the following 4 years, with this total of some $41 million cost over 7 years set against annual losses estimated at $20 million prior to eradication.
More recent studies have also proposed a positive cost-benefit to control of BVDV in dairy herds. In New Zealand, the annual cost of BVDV infection to the dairy industry was estimated to be in excess of NZ $23 million per annum, while a range of control options gave rates of return over a 10-year term as high as 123% (Reichel et al., 2008) .
In the Netherlands, the average annual net costs associated with bovine viral diarrhoea were estimated at €27.8 million for the dairy industry, with the most favourable control option examined yielding a positive cost-benefit of 1.5 over a 10-year period (Santman-Berends et al., 2015) .
A study in Ireland predicted the costs of a national eradication programme in Ireland to be €55 million over a 6-year period, generating a positive cost benefit against the estimated annual losses due to BVDV of €102 million (Stott et al., 2012) .
Parameter 3 -Cost of surveillance and monitoring Surveillance and monitoring costs have not been reported by MSs that have completed eradication but are typically based on targeted serological screening of herds using samples including bulk tank milk samples and blood samples collected at abattoirs (Foddai et al., 2014; Norstr € om et al., 2014) . Surveillance and monitoring costs should therefore be lower than eradication costs. The control and eradication programmes that have either been completed or are currently underway in a number of Member States (Stahl and Alenius, 2012) have had good societal acceptance. Control measures which result in the identification and removal of PI animals are anticipated to have a strongly beneficial impact on the welfare of domestic animals by preventing transient infections in this population. The vaccines currently used in the EU are not expected to have side effects such as fetopathy, induction of mucosal disease and immunosuppression impacting on welfare that have been attributed to MLVs used elsewhere (Kelling, 2004; Ridpath, 2013; Griebel, 2015) .
Parameter 2 -Wildlife depopulation as control measure Depopulation of wildlife has not been implemented as a control measure for BVDV.
Article 7(e)(iv) The environment and biodiversity
Environment
Parameter 1 -Use and potential residuals of biocides or medical drugs in environmental compartments (soil, water, feed, manure) Biocides and medicinal drugs are not used for control of BVDV.
Biodiversity
Parameter 2 -Mortality in wild species Control measures are not anticipated to result in mortality in wild species.
Assessment according to Article 5 criteria
This section presents the results of the expert judgement on the criteria of Article 5 of the AHL about BVD (Table 12 ). The expert judgement was based on Individual and Collective Behavioural Aggregation (ICBA) approach described in detail in the opinion on the methodology (EFSA AHAW Panel, 2017). Experts have been provided with information of the disease fact-sheet mapped into Article 5 criteria (see supporting information, Annex A), based on that the experts indicate their Y/N or 'na' judgement on each criterion of Article 5, and the reasoning supporting their judgement.
The minimum number of judges in the judgement was 13. The expert judgement was conducted as described in the methodological opinion (EFSA AHAW Panel, 2017) . For details on the interpretation of the questions, see Appendix B of the methodological opinion (EFSA AHAW Panel, 2017).
Outcome of the assessment of bovine viral diarrhoea according to criteria of Article 5(3) of the AHL on its eligibility to be listed
As from the legal text of the AHL, a disease is considered eligible to be listed as laid down in Article 5 if it fulfils all criteria of the first set from A(i) to A(v) and at least one of the second set of criteria from B(i) to B(v). According to the assessment methodology (EFSA AHAW Panel, 2017), a criterion is considered fulfilled when the outcome is 'Yes'. According to the results shown in Table 12 , BVD complies with all criteria of the first set and with two criteria of the second set, therefore it is considered eligible to be listed as laid down in Article 5 of the AHL.
Assessment according to Article 9 criteria
This section presents the results of the expert judgement on the criteria of Annex IV referring to categories as in Article 9 of the AHL about bovine viral diarrhoea (Tables 13, 14, 15, 16 and 17) . The expert judgement was based on ICBA approach described in detail in the opinion on the methodology. Experts have been provided with information of the disease fact-sheet mapped into Article 9 criteria (see supporting information, Annex A), based on that the experts indicate their Y/N or 'na' judgement on each criterion of Article 9, and the reasoning supporting their judgement. The minimum number of judges in the judgement was 13. The expert judgement was conducted as described in the methodological opinion (EFSA AHAW Panel, 2017) . For details on the interpretation of the questions, see Appendix B of the methodological opinion (EFSA AHAW Panel, 2017). At least one criterion to be met by the disease:
In addition to the criteria set out above at points 1-2.4, the disease needs to fulfil at least one of the following criteria 3
The disease has a zoonotic potential with significant consequences on public health, including epidemic or pandemic potential OR possible significant threats to food safety N 4(CI) The disease has a significant impact on the economy of the Union, causing substantial costs, mainly related to its direct impact on the health and productivity of animals Y 4(PI) The disease has a significant impact on the economy of the Union, causing substantial costs, mainly related to its direct impact on the health and productivity of animals The disease may result in high morbidity with in general low mortality NC At least one criterion to be met by the disease:
The disease has a zoonotic potential with significant consequences on public health, including epidemic potential OR possible significant threats to food safety N 4(CI) The disease has a significant impact on the economy of the Union, causing substantial costs, mainly related to its direct impact on the health and productivity of animals Y 4(PI) The disease has a significant impact on the economy of the Union, causing substantial costs, mainly related to its direct impact on the health and productivity of animals 
Non-consensus questions
This section displays the assessment related to each criterion of Annex IV referring to the categories of Article 9 of the AHL where no consensus was achieved in form of tables (Tables 18, 19, 20 and 21) . The proportion of Y, N or`na 0 answers are reported, followed by the list of different supporting views for each answer.
At least one criterion to be met by the disease: In addition to the criteria set out above at points 1-2.4, the disease needs to fulfil at least one of the following criteria 3
The disease has a zoonotic potential with significant consequences on public health, or possible significant threats to food safety N 4(CI) The disease has a significant impact on the economy of parts of the Union, mainly related to its direct impact on certain types of animal production systems N 4(PI) The disease has a significant impact on the economy of parts of the Union, mainly related to its direct impact on certain types of animal production systems N 5(a)(CI) The disease has a significant impact on society, with in particular an impact on labour markets N 5(a)(PI) The disease has a significant impact on society, with in particular an impact on labour markets • PI animals infect a large proportion of susceptible bovines which they come in contact with, thus in herds with PI being present, a very high percentage of the herd will be infected.
Supporting Yes for 2.1 (cat.B,C):
• Transmission rate varies depending on the type of infected animal (for PI animals is high for TI is lower) and on the contact structure on the farm.
Reasoning supporting the judgement Supporting Yes for 2.4 (cat.A):
• The disease may result in high morbidity as high numbers of animals may be infected when PI animals are present. Mortality can be significant due to high case-fatality in PI animals.
Supporting Yes for 2.4 (cat.B):
• Most animals are infected with acute infection and then cured. Only PI animals eventually die.
• High number of animals may be TI by a PI.
Supporting Yes for 2.4 (cat.C):
• In endemic situations, there may be some mortality in PI animals, but production losses are the most observed effect. • Currently, the disease is limited to MSs without voluntary control programmes (and those at the start of a programme). Primarily, it is a welfare concern (particularly in calves) in sequelae associated with transient infection. There is evidence for an abortion rate of 44%.
• Secondary infections can have an impact on animal welfare.
Supporting No:
• Most animals are subclinically infected, thus there is no welfare concern. If there really was, trade without any controls would not be freely allowed and eradication would be compulsory rather than voluntary.
Supporting na:
• There is only data about the American situation and no evidence indicating that large numbers of animals could be affected in Europe.
Reasoning supporting the judgement Supporting Yes:
• BVD would impact all MSs if current controls were relaxed. There would be welfare implications for all animals that present with clinical signs.
• If BVDV is introduced to a na € ıve population, there are abortions, stillbirths and weak calves with persistent infection. This affects welfare in the affected farms.
• Currently, there are no EU wide controls on BVD. Some MSs are BVD-free and recognised as such by the EU, others are operating independent control/eradication programmes designed specifically for their own situations and these may be submitted to the EU for recognition. There are a number of licensed BVD vaccines available and even without vaccination most animals are subclinically infected, thus there is, as such, no welfare concern impacting large numbers of animals. The disease has existed and currently exists apparently without such animal welfare impacts on large numbers of animals and trade has been freely allowed without any controls, unless disease freedom or a control programme has been recognised by the EU for individual MSs, without any issue.
3.3.2. Outcome of the assessment of criteria in Annex IV for bovine viral diarrhoea for the purpose of categorisation as in Article 9 of the AHL As from the legal text of the AHL, a disease is considered fitting in a certain category (A, B, C, D or E corresponding to point (a) to point (e) of Article 9(1) of the AHL) if it is eligible to be listed for Union intervention as laid down in Article 5(3) and fulfils all criteria of the first set from 1 to 2.4 and at least one of the second set of criteria from 3 to 5(d) as shown in Tables 13-17. According to the assessment methodology (EFSA AHAW Panel, 2017), a criterion is considered fulfilled when the outcome is 'Yes'. With respect to different type of impact where the assessment is divided into current and potential impact, a criterion will be considered fulfilled if at least one of the two outcomes is 'Y' and, in case of no 'Y', the assessment is inconclusive if at least one outcome is 'NC'.
A description of the outcome of the assessment of criteria in Annex IV for BVD for the purpose of categorisation as in Article 9 of the AHL is presented in Table 22 . According to the assessment here performed, BVD complies with the following criteria of the Sections 1 to 5 of Annex IV of the AHL for the application of the disease prevention and control rules referred to in points (a) to (e) of Article 9(1): 1) To be assigned to category A, a disease needs to comply with all criteria of the first set (1, 2.1-2.4) and according to the assessment BVD complies with criterion 2.3, but not with 1 and 2.2 and this assessment is inconclusive on compliance with criteria 2.1 and 2.4. To be eligible for category A, a disease needs to comply additionally with one of the criteria of the second set (3, 4, 5a-d) and BVD complies with criterion 4, but not with criteria 3, 5a, 5c and 5d and this assessment is inconclusive on compliance with criterion 5b. 2) To be assigned to category B, a disease needs to comply with all criteria of the first set (1, 2.1-2.4) and according to the assessment BVD complies with criteria 1 and 2.3, but not with 2.2 and this assessment is inconclusive on compliance with criteria 2.1 and 2.4. To be eligible for category B, a disease needs to comply additionally with one of the criteria of the second set (3, 4, 5a-d) and BVD complies with criterion 4, but not with criteria 3, 5a, 5c and 5d and this assessment is inconclusive on compliance with criterion 5b. 3) To be assigned to category C, a disease needs to comply with all criteria of the first set (1, 2.1-2.4) and according to the assessment BVD complies with criteria 1, 2.2 and 2.3 and this assessment is inconclusive on compliance with criteria 2.1 and 2.4. To be eligible for category C, a disease needs to comply additionally with one of the criteria of the second set (3, 4, 5a-d) and BVD does not comply with criteria 3, 4, 5a, 5c and 5d and this assessment is inconclusive on compliance with criterion 5b. 4) To be assigned to category D, a disease needs to comply with criteria of Sections 1, 2, 3 or 5 of Annex IV of the AHL and with the specific criterion D of Section 4, with which BVD complies. 5) To be assigned to category E, a disease needs to comply with criteria of Sections 1, 2 or 3 of Annex IV of the AHL and/or the surveillance of the disease is necessary for reasons relating to animal health, animal welfare, human health, the economy, society or the environment. The latter is applicable if a disease fulfils the criteria as in Article 5, with which BVD complies.
Assessment of Article 8
This section presents the results of the assessment on the criteria of Article 8(3) of the AHL about BVD. The Article 8(3) criteria are about animal species to be listed, as it reads below: • According to the assessment here performed, bovine viral diarrhoea meets the criteria as in Sections 4 and 5 of Annex IV of the AHL, for the application of the disease prevention and control rules referred to in points (d) and (e) of Article 9(1) of the AHL. According to the assessment here performed, it is inconclusive whether bovine viral diarrhoea complies with the criteria as in Section 3 of Annex IV of the AHL, for the application of the disease prevention and control rules referred to in point (c) of Article 9(1) of the AHL. Compliance of bovine viral diarrhoea with the criteria as in Section 3 is dependent on a decision on criteria 2.1, 2.4 and 5(b).
TOR 2b: for each of the diseases which was found eligible to be listed for Union intervention, a list of animal species that should be considered candidates for listing in accordance with Article 8 of the AHL.
• According to the assessment here performed, the animal species that can be considered to be listed for bovine viral diarrhoea according to Article 8(3) of the AHL are, as reported in Table 23 in Section 3.4 of the present document, several species of the families Bovidae, Cervidae and Camelidae, giraffe, pronghorn, mouse-deer, pig, rabbit, European hare, and some mouse species as susceptible species; cattle, sheep, rabbit and European hare can be considered to be listed as reservoir species.
